Table: Haba Laboratories Inc - 9-MTH group results
Feb 12 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 10.33 14.08 14.21
(-26.6 pct) (+0.7 pct) (-22.6 pct)
Operating loss 147 mln 1.75 306 mln
(-4.5 pct) (-84.7 pct)
Recurring loss 147 mln 1.73 310 mln
(-6.1 pct) (-84.3 pct)
Net loss 87 mln 1.12 250 mln
(-7.8 pct) (-80.9 pct)
EPS loss 23.03 yen 286.68 yen 66.11 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T